Literature DB >> 25451657

The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitis.

Yoon-Seok Roh1, Rohit Loomba1, Ekihiro Seki1.   

Abstract

Entities:  

Year:  2014        PMID： 25451657      PMCID： PMC4718074          DOI： 10.1053/j.gastro.2014.11.014

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content.

Authors:  Hovsep Mahdessian; Apostolos Taxiarchis; Sergej Popov; Angela Silveira; Anders Franco-Cereceda; Anders Hamsten; Per Eriksson; Ferdinand van't Hooft
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-04       Impact factor: 11.205

2.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Julia Kozlitina; Eriks Smagris; Stefan Stender; Børge G Nordestgaard; Heather H Zhou; Anne Tybjærg-Hansen; Thomas F Vogt; Helen H Hobbs; Jonathan C Cohen
Journal:  Nat Genet       Date:  2014-02-16       Impact factor: 38.330

3.  TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.

Authors:  Yang-Lin Liu; Helen L Reeves; Alastair D Burt; Dina Tiniakos; Stuart McPherson; Julian B S Leathart; Michael E D Allison; Graeme J Alexander; Anne-Christine Piguet; Rodolphe Anty; Peter Donaldson; Guruprasad P Aithal; Sven Francque; Luc Van Gaal; Karine Clement; Vlad Ratziu; Jean-Francois Dufour; Christopher P Day; Ann K Daly; Quentin M Anstee
Journal:  Nat Commun       Date:  2014-06-30       Impact factor: 14.919
  3 in total
  10 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.

Authors:  Elizabeth A O'Hare; Rongze Yang; Laura M Yerges-Armstrong; Urmila Sreenivasan; Rebecca McFarland; Carmen C Leitch; Meredith H Wilson; Shilpa Narina; Alexis Gorden; Kathy A Ryan; Alan R Shuldiner; Steve A Farber; G Craig Wood; Christopher D Still; Glenn S Gerhard; Janet D Robishaw; Carole Sztalryd; Norann A Zaghloul
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

3.  Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments.

Authors:  Zu-Yin Li; Gang Wu; Chen Qiu; Zhi-Jie Zhou; Yu-Peng Wang; Guo-He Song; Chao Xiao; Xin Zhang; Gui-Long Deng; Rui-Tao Wang; Yu-Long Yang; Xiao-Liang Wang
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

4.  Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice.

Authors:  Yanbo Fan; Haocheng Lu; Yanhong Guo; Tianqing Zhu; Minerva T Garcia-Barrio; Zhisheng Jiang; Cristen J Willer; Jifeng Zhang; Y Eugene Chen
Journal:  Gastroenterology       Date:  2016-01-13       Impact factor: 22.682

5.  Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.

Authors:  Martina Goffredo; Sonia Caprio; Ariel E Feldstein; Ebe D'Adamo; Melissa M Shaw; Bridget Pierpont; Mary Savoye; Hongyu Zhao; Allen E Bale; Nicola Santoro
Journal:  Hepatology       Date:  2015-11-16       Impact factor: 17.425

Review 6.  How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?

Authors:  Jake P Mann; Robert K Semple; Matthew J Armstrong
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-16       Impact factor: 5.555

Review 7.  Nonalcoholic fatty liver disease and cardiovascular disease phenotypes.

Authors:  Giandomenico Bisaccia; Fabrizio Ricci; Cesare Mantini; Claudio Tana; Gian Luca Romani; Cosima Schiavone; Sabina Gallina
Journal:  SAGE Open Med       Date:  2020-06-20

8.  PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study.

Authors:  Bisma Rauff; Ali Amar; Badr Alzahrani; Shafiq A Chudhary; Bilal Nasir; Saqib Mahmood; Munir Ahmad Bhinder; Muhammad Faheem
Journal:  BMC Gastroenterol       Date:  2022-08-26       Impact factor: 2.847

9.  The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C.

Authors:  Arthur Ivan N Oliveira; Fernanda M Malta; Patricia Momoyo Y Zitelli; Ana Paula M Salles; Michele S Gomes-Gouvea; Ana Catharina S Nastri; Joao Renato R Pinho; Flair J Carrilho; Claudia P Oliveira; Maria Cássia Mendes-Corrêa; Mario G Pessoa; Daniel F Mazo
Journal:  BMC Gastroenterol       Date:  2021-02-23       Impact factor: 3.067

Review 10.  The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant.

Authors:  Xiaoyu Zhang; Shousheng Liu; Quanjiang Dong; Yongning Xin; Shiying Xuan
Journal:  J Clin Transl Hepatol       Date:  2018-09-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.